were not significant in the fully adjusted models. Conclusions: These findings suggest that higher OBS is associated with lower prevalence of CKD. Lack of association with ESRD incidence in the multivariable analyses indicates that temporal relation between OBS and renal damage remains unclear.
Introduction
Oxidative stress has been implicated both in the pathogenesis of chronic kidney disease (CKD) and in cardiovascular complications of CKD such as atherosclerosis [1] [2] [3] [4] . Oxidative stress is defined as an imbalance between pro-and antioxidants in favor of pro-oxidants [5] . CKD is associated with increased levels of reactive oxygen species and nitrogen species [5, 6] . This process is observed in early CKD and may contribute to both progressive decline in the glomerular filtration rate (GFR) and vascular complications [6] [7] [8] . Individuals with CKD and compromised nutritional status have more evidence of oxidative stress than the well-nourished ones [9, 10] .
The balance between pro-and antioxidants is largely determined by endogenous enzymatic mechanisms [11, 12] . However, exogenous factors such as diet, medications and lifestyle are major environmental sources for both pro-and antioxidants [13] . Ascertaining the individual effects of oxidative balance-related exposures is difficult because they are small, may be correlated and there may be existing biological interaction involving pro-and antioxidant factors [14] . In 2002, Van Hoydonck et al. [15] proposed an oxidative balance score (OBS) as a composite measure of oxidative stress-related exposures. OBS uses information about the dietary micronutrient pro-and antioxidants, antioxidant medication use and pro-oxidative smoking status to summarize pro-and antioxidant exposure status [15, 16] . Data from population-based studies on pro-and antioxidant exposure status in individuals with CKD are sparse and focus on individual micro and macronutrients [17, 18] or dietary patterns [19] and their association with outcomes such as end-stage renal disease (ESRD) and mortality.
The OBS has been shown to correlate inversely with all-cause mortality [15] , and with the risk of sporadic colorectal adenoma [12, 20, 21] and colorectal cancer [22] . However, the associations between OBS and measures of CKD, including estimated GFR (eGFR), albuminuria and incident ESRD, have not been previously studied.
Subjects and Methods

Study Design
The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study is a national, population-based prospective study to examine reasons for variation in stroke incidence and mortality in the United States. Details on recruitment and data collection were reported previously [23] . Briefly, between January 2003 and October 2007, more than 30,000 healthy volunteers over the age of 45 years were randomly selected and recruited with planned equal recruitment of men and women and oversampling of African Americans and residents of the 8 southeastern US states because they have higher stroke mortality than the rest of the United States. These states are divided into the 'stroke buckle' (coastal plain regions of Georgia, North and South Carolina) and the 'stroke belt' (the remaining regions of Georgia, North and South Carolina, Mississippi, Alabama, Tennessee, Louisiana and Arkansas) [19] . Trained personnel collected data by using a computer-assisted telephone survey to obtain sociodemographic factors and other information. Subsequently, a health professional visited the participants' homes to collect anthropomorphic variables as well as blood and urine samples. At this appointment, a 1998 Block Food Frequency Questionnaire (98-block FFQ; Nutrition Quest, Berkeley, Calif., USA) was left with the participant to be self-administered and returned to the data coordinating center. Various versions of the block FFQ had been validated in different populations and found to correlate with diet records, most correlations being in the 0.5-0.6 range [24] . Although compared to diary entry for nutritional intake, FFQ tends to underestimate micronutrient intake while the total energy intake is overestimated but this measurement error is distributed evenly across study sub-populations [25] [26] [27] .
The REGARDS study was approved by the institutional review boards at all the participating centers and all participants provided informed consent.
Participants were then contacted by telephone every 6 months to capture outcomes of interest such as stroke. ESRD status was assessed by linkage with the United States Renal Data System (USRDS). The USRDS is a registry of ESRD, and it captures over 95% of incident cases in the United States [28] .
Population
From a total number of 30,239 participants, we excluded 8,686 individuals who did not have data from the block FFQ (28.6%). Of the remaining 21,553, we excluded individuals who were found on record linkage to have already been treated for ESRD (n = 23) at the time of baseline interview, those with missing albumin/creatinine ratio (ACR; n = 943), then those with missing eGFR (n = 576) and those with missing data on any OBS component (n = 550). A total of 19,461 participants were included in the final analysis. Excluded individuals differed only by race and were predominantly black (57.6%).
OBS
The main exposure (OBS) was calculated by summing up 13 a priori-defined pro-and antioxidant exposure factors ( table 1 ) as described previously [13, 15] . These factors include intake of polyunsaturated fatty acid (PUFA), iron, selenium, vitamin C, vitamin E, α-carotene, β-carotene, lutein, lycopene, and cryptoxanthin intake; and use of aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and alcohol [15] . Smoking was excluded from the original OBS because smoking is a well-known strong risk factor for CKD [29] [30] [31] [32] [33] [34] . A higher OBS is reflective of higher antioxidant levels and low pro-oxidant levels and a lower score is reflective of lower antioxidant levels and higher pro-oxidant levels. The dietary data were collected at baseline using the FFQ, which consists of 107 items that assesses dietary intake over the previous year. The FFQ has been described in detail in previous studies [19, 35] . Completed questionnaires were scanned and sent to Nutrition Quest TM (Berkeley, Calif., USA) for analysis of nutrition content.
The continuous dietary variables reflecting pro-oxidant (unsaturated fat and iron) and antioxidant (vitamin C, lycopene, α-carotene, β-carotene, lutein, β-cryptoxanthin, vitamin E and selenium) exposures were divided into low, medium and high categories based on each exposure's sex-specific tertiles. For antioxidants, the 1st through 3rd tertiles were assigned 0 through 2 points, respectively, whereas the corresponding point assignment for prooxidants was the reverse (0 points for the highest tertile and 2 points for the lowest tertile).
A similar scoring approach was used for pro-and antioxidant categorical variables. For antioxidant aspirin and NSAID use, 0 points were assigned to participants with no regular use, 1 point to those with unknown or missing data, and 2 points to those with regular use. For pro-oxidant alcohol consumption, nondrinkers, moderate drinkers (1-7 drinks/week for women and 1-14 drinks/week for men) and heavy drinkers (>7 drinks/week for women and >14 drinks/week for men) received 2, 1 and 0 points, respectively ( table 1 ) .
Outcome Measures
We defined albuminuria as ACR >30 mg/g at baseline. Macroalbuminuria was defined as ACR >300 mg/g. CKD was defined as eGFR <60 ml/min/1.73 m 2 calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. The eGFR at baseline was calculated using the CKD-EPI [36] equation using isotope dilution mass spectrometry-calibrated creatinine. Incident ESRD was determined by linkage of the REGARDS study participants to the USRDS via personal identifiers. ESRD was defined as chronic renal failure requiring permanent renal replacement therapy such as dialysis or transplant [28] . ESRD status was determined through August 31, 2009.
Covariates
Age, sex, race, smoking, income and educational attainment were self-reported. Region was classified as stroke belt, stroke buckle and other; caloric intake was obtained from the FFQ and analyzed as a continuous variable. We adjusted for systolic blood pressure (SBP), diastolic blood pressure (DBP), baseline eGFR and total cholesterol as continuous variables. Coronary artery disease (CAD) was defined as history of heart disease (self-reported myocardial infarction), coronary artery bypass, angioplasty or stenting OR evidence of myocardial infarction via electrocardiogram. Diabetes was defined as fasting blood glucose >126 mg/dl, non-fasting blood glucose >200 mg/dl or self-reported use of insulin or oral hypoglycemic agents. Statin use was self-reported. The waist circumference was measured in centimeters during the in-home visit. Physical activity was assessed by asking about the number of times participants engaged in intense physical activity enough to work up a sweat (we assessed physical activity as 1-3 times a week and above vs. other).
Statistical Analysis
The baseline characteristics of the study population were reported for the overall population and across OBS quartiles. Differences in baseline characteristics among the 4 OBS quartiles were tested using analysis of variance for continuous variables and chisquare statistics for categorical variables.
In all analyses, the exposure was OBS (in quartiles and as a continuous variable) and the dependent variables of interest were albuminuria, macroalbuminuria, CKD and ESRD. The first OBS quartile (predominance of pro-oxidants) was used as the reference group. ORs and 95% CIs were estimated using logistic regression for albuminuria and CKD. Adjusted hazards ratios (HRs) and 95% CIs were estimated using the Cox proportional hazards model for ESRD. We tested the PH assumption by examination of log-log survival curves, Schoenfeld residuals and the extended Cox models and found that the PH assumption was satisfied. The trend tests for OBS (from lower to higher quartiles) in the crude and adjusted models were analyzed by assessing the OBS quartiles as an ordinal variable.
We developed 2 models to adjust for various confounders based on prior literature review. Model 1 adjusted for age, sex, race, region and calories, and model 2 adjusted for variables in model 1 plus body mass index, smoking, waist circumference, physical activity, education, income, SBP, DBP, total cholesterol, CAD, diabetes and statin medications. In studying ESRD, we also adjusted for albuminuria and baseline eGFR in addition. All reported p values are 2-sided with an alpha of 0.05.
We conducted sensitivity analysis with NSAIDs and aspirin removed from the OBS, and we also investigated the association between the individual components of the OBS and albuminuria and CKD. 
Results
There were 19,461 subjects included in the analyses. Their mean age (SD) was 64.8 (9.2) years, and 55.2% were women and 67.4% were white ( table 2 ). The mean (SD) OBS was 12.7 (3.7), with median of 13 and interquartile range of 10-15. The proportion of white participants was lower in patients with lower versus those with higher OBS (Q1 = 66.3% vs. Q4 = 69.6%).
Higher OBS quartiles (i.e., those with increasing predominance of antioxidants and lower pro-oxidants) included lower proportions of participants in the stroke belt and buckle region. Higher OBS quartiles were associated with lower likelihood of smoking, greater income and education level, and higher likelihood of self-reported hypertension and statin and diabetic medication use. Table 1 (online suppl. table 1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000441623) shows the distribution of the individual score components by OBS quartiles. NSAID use was higher in higher versus lower OBS quartiles. Aspirin use also higher in higher versus lower OBS quartiles. The prevalence of heavy alcohol use was lowest in Q4. The intake of antioxidants (vitamin C, α-carotene, β-carotene, vitamin E, lutein, and lycopene and cryptoxanthin levels) was highest in Q4. However, pro-oxidant PUFAs and iron were also higher in Q4. Table 3 shows the crude association between the OBS quartiles and the outcomes: albuminuria, CKD and ESRD. The crude ORs (95% CI) were estimated for CKD and albuminuria, and the crude HRs (95% CI) were estimated for ESRD. A total of 2,519 (12.9%) had prevalent albuminuria, 1,957 participants had prevalent CKD (10.0%) and 90 (0.46%) participants developed ESRD over a median follow-up period of 3.5 years (range 2.14-4.32 years). In summary, the crude associations (OR and HR) reflecting the association between OBS quartile and each of the individual outcomes was significant for macroalbuminuria (p for trend <0.01) but not for albuminuria, CKD or ESRD ( table 3 ) . When analyzed as a continuous variable, in the crude model, for every 5-unit increase in the OBS, the odds of having albuminuria was 0.98 times the odds of not having albuminuria (OR 0.98, 95% CI 0.93-1.04) and the odds of having macroalbuminuria was 0.78 times the odds of no macroalbuminuria (OR 0.78, 95% CI 0.68-0.90; table 4 ). The results for a 10-unit increase in OBS are also shown in table 3 . In the crude model, for every 5-unit increase in OBS, the odds Crude models showing the association between OBS quartiles and the outcomes: albuminuria, CKD and ESRD Total, For macroalbuminuria, albuminuria and CKD, model 1 is adjusted for age, sex, race, region and calories; model 2 is adjusted for age, sex, race, region, calories, body mass index, smoking, waist circumference, physical activity, education, income, diabetes, statin medications, cardiovascular disease, SBP, DBP and total cholesterol.
of CKD was 0.99 times the odds of not having CKD (OR 0.99, 95% CI 0.93-1.06). For every 5-unit increase in OBS in the crude model, the likelihood of developing ESRD was 0.82 that of not developing ESRD (HR 0.75, 95% CI 0.55-1.01). The crude associations between OBS as a continuous variable and the outcomes (albuminuria, CKD and ESRD) were not statistically significant. Table 4 shows the associations of OBS with albuminuria, macroalbuminuria, CKD and ESRD, adjusted for various confounders. There was also no significant association between OBS quartiles and albuminuria in the fully adjusted model; however, for macroalbuminuria, compared to Q1, Q3 (OR 0.73, 95% CI 0.55-0.97) and Q4 (OR 0.67, 95% CI 0.49-0.92) were associated with a lower odds of macroalbuminuria ( table 4 ) . The trend for macroalbuminuria was also significant for model 1 (p trend <0.01) but not for model 2 (p trend = 0.19) OBS in the highest versus lowest quartile was associated with significantly lower odds of CKD (OR 0.83, 95% CI 0.71-0.96) in model 1. The trend for OBS was also significant for CKD in model 1 (p trend = 0.02). This statistically significant inverse association remained after adjusting for other covariates in model 2 (OR 0.71, 95% CI 0.60-0.831). Those in Q4 had a 29% lower odds of having an eGFR <60 ml/ min/1.73 m 2 . The trend test for OBS in model 2 was also statistically significant (p trend <0.0001).
Using OBS as a continuous variable, for a 5-unit increase in OBS, the odds of having macroalbuminuria was 0.77 times the odds of no macroalbuminuria in model 1 but not significant in model 2. In the crude models, there was no association between the odds of having CKD and a 5-unit increase in OBS ( table 3 ) . However, in model 1, ( table 4 ), the odds of having CKD versus no CKD for 5-unit increase in OBS was 0.93, and this was statistically significant (95% CI 0.86-0.99). In the fully adjusted model, the odds of having CKD versus no CKD for a 5-unit increase in OBS was 0.90 (95% CI 0.84-0.97). The association between OBS and ESRD was not statistically significant ( tables 3 and 4 ).
A sensitivity analysis excluding NSAIDs and aspirin from the OBS showed that the association between the OBS and CKD was significant in the crude and adjusted models (p for trend <0.001 in all the models). In addition, Q2 (OR 0.86, 95% CI 0.75-1.00) and Q3 (OR 0.71, 95% CI 0.60-0.83) were associated with significantly lower odds of having CKD. The results were also similar when OBS was analyzed as a continuous variable (online suppl. table 2).
OBS was significantly associated with albuminuria using linear regression models. A 5-unit increase in OBS was associated with a 7.30 mg/g reduction in albuminuria in the crude model (p < 0.01), and a reduction of 6.91 mg/g reduction in albuminuria (p < 0.01). For a 5-unit increase in OBS, the eGFR changes by 0.57 ml/min/1.73 m 2 (p < 0.01) in the crude model and 0.88 ml/min/1.73 m 2 in the fully adjusted model (p < 0.001; online suppl. table 3).
When we investigated the crude association between albuminuria and the individual pro-and antioxidant, we found unsaturated fats (p < 0.01), iron (p < 0.01), α-carotene (p < 0.0001), lutein (p < 0.01), NSAIDs (p < 0.05), smoking (p < 0.0001), selenium (p < 0.05), aspirin (p < 0.0001) and alcohol (p < 0.0001; online suppl. table 4).
The crude analysis of the association between pro and anti-oxidant factors and CKD showed that unsaturated fat (p < 0.0001), iron (p < 0.05), lycopene (p < 0.01), α-carotene (p < 0.001), β-carotene (p < 0.0001), lutein (p < 0.0001), β-cryptoxanthin (p < 0.01), α-tocopherol (p < 0.0001), smoking (p < 0.001), aspirin (p < 0.0001) and alcohol (p < 0.001) were all individually associated with CKD (online suppl. table 4).
Discussion
We examined the association between OBS, albuminuria, CKD and ESRD and found that higher OBS quartiles (which reflect an increased antioxidant effect) were associated with lower prevalence of CKD, as measured by eGFR <60 ml/min/1.73 m 2 and associated with albuminuria in the linear regression models and macroalbuminuria in the crude and partially adjusted models but not associated incident ESRD.
Our study suggests the greater the shift from pro-to antioxidant exposures (as measured by higher OBS), the lower the odds of CKD as defined by an eGFR <60 ml/ min/1.73 m 2 . To our knowledge, this is the first study that utilizes the OBS to determine the association between the balance of pro-and antioxidant exposure and kidney disease.
The lack of association seen between OBS and incident ESRD are inconclusive due to the small number of participants who developed ESRD and the relatively short follow-up period. This warrants further investigation into the association between OBS and ESRD when there is longer follow-up data available. Other possible explanations of this are that since the FFQ is measured at baseline, secular dietary changes, particularly those that may occur among participants with prevalent CKD who have many dietary restrictions are not accounted for. It also suggests that the temporal association between OBS and renal damage remains unclear.
There was a significant inverse association between OBS and CKD as defined by eGFR <60 ml/min/1.73 m 2 that became more pronounced as we adjusted for potential confounders. Current evidence suggests that CKD is a pro-oxidant state as evidenced by the increase in oxidative markers in atherosclerotic lesions of patients with CKD as well as in circulating plasma of CKD patients [37] [38] [39] . Our results suggest that the OBS may be a measure of pro-and antioxidant exposure in CKD. Measuring the OBS may be the first step in detecting pro-and antioxidant exposure in individuals at risk for development of an eGFR <60 ml/min/1.73 m 2 . These results need to be further validated using incident CKD cases in a dedicated CKD cohort.
OBS has been validated in previous studies. Kong et al. [40] validated the OBS in all-cause, cancer and non-cancer mortality in the REGARDS cohort. Dash et al. [21] also validated the OBS in a pooled case-control study of incident, sporadic colorectal adenoma. OBS was also found to be associated with circulating biomarkers of oxidative stress, F2-isoprostanes and C-reactive protein, in colorectal adenoma [41] .
The strengths of the study include the use of a large population cohort. The OBS provides a measure whereby the effects of pro-and antioxidant factors in the diet and medications are summed up, and this 'effect' or 'balance' can be used to determine outcomes. The a priori selection of cutoffs in the components of OBS reduces subjectivity in measurement [12] .
The limitations of the study include the small number of incident ESRD cases in the cohort and misclassification due to self-reported data, particularly dietary assessments from the food frequency questionnaire, to determine the OBS. Although dietary questionnaires are prone to recall bias and nutritional intake recorded may be inaccurate, on the population level, they provide a satisfactory classification of nutrient intake [27, 42, 43] . The study of CKD and albuminuria was cross-sectional with selection bias from missing data and residual confounding. The OBS was limited to dietary/lifestyle exposures and included no endogenous measures of antioxidant cell function [44, 45] .
The goal of identifying the individuals at risk for higher oxidative stress is to institute aggressive risk modification. This study suggests that higher OBS may be independently associated with lower prevalence of CKD and may represent a modifiable risk factor for CKD.
